The safety and effectiveness of ledipasvir-sofosbuvir in adolescents 12-17 years old with hepatitis C virus genotype 1 infection

William F. Balistreri*, Karen F. Murray, Philip Rosenthal, Sanjay Bansal, Chuan Hao Lin, Kathryn Kersey, Benedetta Massetto, Yanni Zhu, Bittoo Kanwar, Polina German, Evguenia Svarovskaia, Diana M. Brainard, Jessica Wen, Regino P. Gonzalez-Peralta, Maureen M. Jonas, Kathleen Schwarz

*Corresponding author for this work

    Research output: Contribution to journal › Article › peer-review

    151 Citations (Scopus)

    Fingerprint

    Dive into the research topics of 'The safety and effectiveness of ledipasvir-sofosbuvir in adolescents 12-17 years old with hepatitis C virus genotype 1 infection'. Together they form a unique fingerprint.

    Pharmacology, Toxicology and Pharmaceutical Science